---
granola_id: e2274b50-4717-4895-b0d0-9bd5b01c9418
title: "Virtue <> ZoomLogi"
type: note
created: 2026-01-08T20:07:52.435Z
updated: 2026-01-08T20:31:11.051Z
attendees: 
  - saad@zoomlogi.com
  - olivier@zoomlogi.com
  - ek@virtuevc.com
---
### Product Development & Market Focus

- Three key product pillars:
	- Control tower (traditional logistics software + alerting)
	- AI workflow components for communication automation
	- Shareability/visibility ecosystem for multi-party access
- Customer sophistication requests from Katanan:
	- Advanced alerting, temperature monitoring, reporting capabilities
	- Different SOPs per customer for issue handling workflows
	- Custom reporting templates based on issue types
- Progress on sophistication features:
	- Added downloadable proof of delivery + chain of custody
	- Building no-code workflow system for automated SOPs
	- Developing view-only platforms for hospitals/specialty pharmacies (Q1-Q2)
- Vertical market refinement:

### Hiring & Team Expansion

- Head of Engineering search progress:
	- Shifted criteria: 10 years experience (vs 15), early-stage startup background required
	- Using Slope + Single Sprout recruiting firms
	- Amal (Chicago candidate) - 8 years experience, fintech/AI background, coding exercise scheduled
	- Key learnings: SF engineer compensation 3x higher than reported benchmarks
- Enterprise Sales hire closed:
	- Candidate from GHX (80% health system market share, supply chain data)
	- Starting early March, based in Idaho
	- First dedicated health system + specialty pharma sales role
- Next AE hiring criteria:
	- Different vertical focus requiring specialized knowledge
	- Proven repeatable process with 2-3 proof points in segment
	- Large addressable market (hundreds/thousands of prospects)

### Revenue Pipeline & Cardinal Health Update

- Cardinal Health pilot performing well:
	- Consistent 3-month growth: users, shipments, client count
	- On-site meeting January 20th for post-pilot review
	- Currently engaging 3 Cardinal teams: customer service, recovery missions, reporting
	- Target: close agreement by end of Q1
- First specialty pharma customer closed last month
- H1 revenue heavily dependent on Cardinal conversion

Chat with meeting transcript: https://notes.granola.ai/t/16b242fa-16d2-4a10-9138-2396b2a584f2
